3gkw: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:3gkw.png|left|200px]] | |||
[[Image:3gkw. | |||
<!-- | <!-- | ||
| Line 20: | Line 19: | ||
==About this Structure== | ==About this Structure== | ||
[[3gkw]] is a 2 chain structure of [[Monoclonal Antibody]] with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3GKW OCA]. | |||
==See Also== | |||
*[[Monoclonal Antibody]] | |||
==Reference== | ==Reference== | ||
| Line 34: | Line 36: | ||
[[Category: Immune system]] | [[Category: Immune system]] | ||
[[Category: Immunoglobulin fold]] | [[Category: Immunoglobulin fold]] | ||
Revision as of 21:45, 26 December 2010
Crystal structure of the Fab fragment of Nimotuzumab. An anti-epidermal growth factor receptor antibody
Template:ABSTRACT PUBMED 19584289
About this Structure
3gkw is a 2 chain structure of Monoclonal Antibody with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See Also
Reference
- Talavera A, Friemann R, Gomez-Puerta S, Martinez-Fleites C, Garrido G, Rabasa A, Lopez-Requena A, Pupo A, Johansen RF, Sanchez O, Krengel U, Moreno E. Nimotuzumab, an antitumor antibody that targets the epidermal growth factor receptor, blocks ligand binding while permitting the active receptor conformation. Cancer Res. 2009 Jul 15;69(14):5851-9. Epub 2009 Jul 7. PMID:19584289 doi:10.1158/0008-5472.CAN-08-4518
